Chen Shu-Chih

Avg. Two Year Performance

(90%) Avg. Purchase Return
(38%) Compound
87% Avg. Sale Return
37% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return39%(11%)(20%)(66%)(90%)
Purchase Success Rate1 of 20 of 20 of 20 of 20 of 2
Average Sale Return69%57%70%78%87%
Sale Success Rate1 of 11 of 11 of 11 of 11 of 1

Atossa Therapeutics, Inc.

Drugs » Diagnostic Substances

Director:

Holdings: 4.35M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--